Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 22,575,038 shares, a decline of 6.5% from the July 14th total of 24,133,552 shares. Approximately 27.6% of the shares of the company are short sold. Based on an average daily trading volume, of 1,039,897 shares, the days-to-cover ratio is presently 21.7 days.

In other news, Director William Grieco sold 2,000 shares of the business’s stock in a transaction on Friday, June 16th. The shares were sold at an average price of $45.42, for a total transaction of $90,840.00. Following the sale, the director now directly owns 47,013 shares of the company’s stock, valued at $2,135,330.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Reeve B. Waud sold 1,240,000 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $51.72, for a total transaction of $64,132,800.00. The disclosure for this sale can be found here. Insiders have sold 2,136,347 shares of company stock worth $105,383,249 over the last three months. Corporate insiders own 11.10% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its stake in shares of Acadia Healthcare by 65.6% in the second quarter. BlackRock Inc. now owns 8,523,077 shares of the company’s stock valued at $420,871,000 after buying an additional 3,377,291 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Acadia Healthcare by 0.8% in the first quarter. JPMorgan Chase & Co. now owns 7,705,975 shares of the company’s stock valued at $335,980,000 after buying an additional 59,735 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 8.9% in the second quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock valued at $308,849,000 after buying an additional 511,299 shares during the last quarter. Aristotle Capital Management LLC purchased a new stake in shares of Acadia Healthcare during the first quarter valued at $140,071,000. Finally, FMR LLC increased its stake in shares of Acadia Healthcare by 26.4% in the second quarter. FMR LLC now owns 2,775,451 shares of the company’s stock valued at $137,052,000 after buying an additional 580,449 shares during the last quarter.

Acadia Healthcare (NASDAQ:ACHC) opened at 52.38 on Friday. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.73. The firm has a 50 day moving average of $50.30 and a 200-day moving average of $44.67. The firm has a market cap of $4.60 billion, a P/E ratio of 575.60 and a beta of 1.15.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The business had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.73 earnings per share. On average, equities research analysts forecast that Acadia Healthcare will post $2.45 earnings per share for the current year.

ACHC has been the topic of a number of research analyst reports. William Blair initiated coverage on shares of Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating on the stock. Zacks Investment Research raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Friday, April 28th. Jefferies Group LLC set a $55.00 price objective on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Thursday, June 1st. Leerink Swann lowered shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. Finally, Cantor Fitzgerald reissued a “hold” rating and set a $45.00 price objective on shares of Acadia Healthcare in a report on Wednesday, April 26th. Five equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Acadia Healthcare has a consensus rating of “Buy” and a consensus price target of $59.21.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.dailypolitical.com/2017/08/12/acadia-healthcare-company-inc-achc-sees-significant-decrease-in-short-interest.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.